Literature DB >> 515872

Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.

G H Blekkenhorst, L Eales, N R Pimstone.   

Abstract

Uroporphyrinogen decarboxylase was measured in the presence of ferrous iron, using mitochondria-free rat liver extracts as enzyme source. The activity of the enzyme was found to be increased at concentrations of ferrous iron from 0,01 mM, with maximal activity exhibited from 0,1 mM. Enzyme kinetics indicate that uroporphyrinogen decarboxylase reversibly binds ferrous iron, with a binding constant of approximately 5 x 10(4) mol-1. It is proposed that the effect of phlebotomy on patients with porphyria cutanea tarda is to mobilze storage iron in the liver to the active ferrous form, which activates hepatic uroporphyrinogen decarboxylase, the enzyme which is defective in this syndrome, with resultant clinical and biochemical remission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 515872

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

Review 1.  The role of transferrin in the mechanism of cellular iron uptake.

Authors:  K Thorstensen; I Romslo
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

2.  Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.

Authors:  H De Verneuil; S Sassa; A Kappas
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

3.  Conversion of 5-aminolaevulinate into haem by liver homogenates. Comparison of rat and chick embryo.

Authors:  J F Healey; H L Bonkowsky; P R Sinclair; J F Sinclair
Journal:  Biochem J       Date:  1981-09-15       Impact factor: 3.857

4.  Iron and the liver: acute effects of iron-loading on hepatic heme synthesis of rats. Role of decreased activity of 5-aminolevulinate dehydrase.

Authors:  H L Bonkowsky; J F Healey; P R Sinclair; J F Sinclair; S I Shedlofsky; G H Elder
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.